课题基金 / 基金详情

MATRIX PROTEINS OF ENVELOPED VIRUSES

MATRIX PROTEINS OF ENVELOPED VIRUSES
有包膜病毒的基质蛋白
批准号:
3131870
负责人:
ROBERT R WAGNER
金额:
$11.02万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-01-01 至 1987-12-31

项目摘要

项目成果

ROBERT R WAGNER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The peripheral matrix (M) protein of negative-strand viruses, such as vesicular stomatitis virus (VSV), plays a key role in virion assembly and transcription regulation. We propose to characterize the molecular basis for the membrane binding, nucleocapsid binding, and transcription-inhibition functions of the VSV M protein by the following chemical, immunological, genetic, and biophysical methods: 1. Peptides generated by cleavage with specific chemicals and proteases will be sequenced, mapped, and tested, along with synthetic oligopeptides, for their capacity to bind to phospholipid vesicles and nucleocapsids, and to inhibit viral transcription. 2. Monoclonal antibodies to M protein have been prepared and will be tested for their reactivity with specific peptides and for their capacity to inhibit the various biological functions of M protein and its peptides. 3. Complementation group III temperature-sensitive mutant M proteins, restricted in transcription-inhibition, and revertant M proteins will be tested for their capacity to bind to lipid vesicles, nucleocapsids, and specific monoclonal antibodies. 4. Recombinant DNA clones of mutant, revertant, and wild-type M-protein genes will be prepared and their cDNAs sequenced to identify the sites of lesions in M proteins defective in binding to vesicles and nucleocapsid and in transcription-inhibition. We eventually hope to prepare cDNA clones of M genes in expression vectors to make site-directed defective M proteins. 5. Biophysical studies with wild-type and mutant M proteins and their peptides will be performed to assay perturbations of membrane dynamics measured by fluorescence depolarization reacting with membranes as determined by circular dichroism spectroscopy. 6. M proteins of VSV-New Jersey and A/WSN/33 influenza virus and their monoclonal antibodies will also be examined by these methods for comparison with the functional and evolutionary relatedness of the M protein of VSV-Indiana.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Regulation of viral transcription by the matrix protein of vesicular stomatitis virus probed by monoclonal antibodies and temperature-sensitive mutants.
通过单克隆抗体和温度敏感突变体探测水疱性口炎病毒基质蛋白对病毒转录的调节。
DOI: 10.1128/jvi.56.2.386-394.1985
发表时间: 1985
期刊: Journal of virology
影响因子: 5.4
作者: [Pal,R, Grinnell,BW, Snyder,RM, Wagner,RR]
通讯作者: Wagner,RR
Site-specific mutations in vectors that express antigenic and temperature-sensitive phenotypes of the M gene of vesicular stomatitis virus.
表达水泡性口炎病毒 M 基因抗原和温度敏感表型的载体的位点特异性突变。
DOI: 10.1128/jvi.62.10.3729-3737.1988
发表时间: 1988
期刊: Journal of virology
影响因子: 5.4
作者: [Li,Y, Luo,LZ, Snyder,RM, Wagner,RR]
通讯作者: Wagner,RR
Mapping regions of the matrix protein of vesicular stomatitis virus which bind to ribonucleocapsids, liposomes, and monoclonal antibodies.
水疱性口炎病毒基质蛋白与核糖核衣壳、脂质体和单克隆抗体结合的区域图谱。
DOI: 10.1128/jvi.58.3.860-868.1986
发表时间: 1986
期刊: Journal of virology
影响因子: 5.4
作者: [Ogden,JR, Pal,R, Wagner,RR]
通讯作者: Wagner,RR
Point mutations in glycoprotein gene of vesicular stomatitis virus (New Jersey serotype) selected by resistance to neutralization by epitope-specific monoclonal antibodies.
水疱性口炎病毒(新泽西血清型)糖蛋白基因的点突变通过表位特异性单克隆抗体的中和抗性进行选择。
DOI: 10.1016/0042-6822(88)90274-7
发表时间: 1988
期刊: Virology
影响因子: 3.7
作者: [Luo,LH, Li,Y, Snyder,RM, Wagner,RR]
通讯作者: Wagner,RR
8
    CORE--DEVELOPMENT FUNDS
    • 批准号:
      6618868
    • 项目类别:
    • 资助金额:
      $7.89万
    • 财政年份:
      2002
    • 负责人:
      ROBERT R WAGNER
    • 依托单位:
    CORE--DEVELOPMENT FUNDS
    • 批准号:
      6501444
    • 项目类别:
    • 资助金额:
      $7.89万
    • 财政年份:
      2001
    • 负责人:
      ROBERT R WAGNER
    • 依托单位:
    CORE--DEVELOPMENT FUNDS
    • 批准号:
      6352735
    • 项目类别:
    • 资助金额:
      $15.27万
    • 财政年份:
      2000
    • 负责人:
      ROBERT R WAGNER
    • 依托单位:
    CORE--DEVELOPMENT FUNDS
    • 批准号:
      6311505
    • 项目类别:
    • 资助金额:
      $15.27万
    • 财政年份:
      2000
    • 负责人:
      ROBERT R WAGNER
    • 依托单位:
    海外基金